Enhancing effect of bromovinyldeoxyuridine on antitumour activity of 5-fluorouracil in mice bearing MOPC-315 plasmacytomas
- 1 November 1986
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 54 (5) , 847-851
- https://doi.org/10.1038/bjc.1986.250
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The difference between 5-fluorouracil and melphalan in their ability to promote antitumor immune response against MOPC-315 plasmacytomaCancer Immunology, Immunotherapy, 1986
- EFFECT OF (E)-5-(2-BROMOVINYL)URACIL ON THE CATABOLISM AND ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL IN RATS AND LEUKEMIC MICE1986
- CELLULAR BASIS FOR THE INEFFICACY OF 5-FU IN HUMAN-COLON CARCINOMA1985
- Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogsPharmacology & Therapeutics, 1984
- Melphalan-mediated potentiation of antitumor immune responsiveness of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumorCancer Immunology, Immunotherapy, 1984
- Regeneration of the antivirel drug(E)-5-(2-bromovinyl)-2′ -deoxyuridinein vivoNucleic Acids Research, 1984
- Adaptation of murine MOPC-315 myeloma cells to growth in vitro and further characterization of their C-type virusesPublished by Elsevier ,1978
- Mouse myeloma proteins with antihapten antibody activity. Protein produced by plasma cell tumor MOPC-315Biochemistry, 1968